P Li1, R Jiang2, L Li3, C Liu1, F Yang1, Y Qiu1. 1. Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, PR China. 2. Liaoyang Diabetes Hospital, Liaoyang, PR China. 3. 1] Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, PR China [2] The Liaoning Provincial Key Laboratory of Endocrine Diseases, Shenyang, PR China.
Abstract
BACKGROUND/ OBJECTIVES: To investigate the association of adiponectin and its gene polymorphisms with metabolic syndrome (MetS) and cardiovascular disease (CVD) risk factors in Chinese adolescents. SUBJECTS/ METHODS: This cross-sectional study enrolled 919 healthy middle school students (aged 11-16 years; 46.7% females). All participants underwent anthropometric and biochemical examinations, and MetS was diagnosed using 2007 International Diabetes Federation criteria. The presence of adiponectin and its genotypes of single nucleotide polymorphisms (SNPs) rs266729 (-11377C/G), rs2241766 (+45T/G) and rs1501299 (+276G/T) was detected. RESULTS: (1) Serum adiponectin levels were negatively correlated with numerous CVD risk factors (all P<0.05), and following adjustments for confounding factors, a lower adiponectin level was an independent risk factor for MetS (odds ratio=5.59; 95% confidence interval: 1.90, 16.41). Central obesity and low levels of high-density lipoprotein cholesterol were positively associated with MetS and reduced serum adiponectin levels. (2) The genotype and frequencies of SNP-11377 and SNP+276 in a MetS group and non-MetS group were not significantly different. Subjects with genotype SNP+45 GG were at higher risk for MetS compared with subjects with genotypes SNP+45 TT (P=0.033) or TT+TG (P=0.021). Subjects with genotype SNP+276 TT or TT+TG had higher levels of serum adiponectin compared with subjects with SNP+276 GG (P=0.012 and 0.014, respectively). CONCLUSIONS: Adiponectin may be used as a predictive biomarker of MetS, and shows a significant association with CVD risk factors in Chinese adolescents. Adiponectin gene polymorphisms are associated with serum adiponectin concentrations and the presence of MetS.
BACKGROUND/ OBJECTIVES: To investigate the association of adiponectin and its gene polymorphisms with metabolic syndrome (MetS) and cardiovascular disease (CVD) risk factors in Chinese adolescents. SUBJECTS/ METHODS: This cross-sectional study enrolled 919 healthy middle school students (aged 11-16 years; 46.7% females). All participants underwent anthropometric and biochemical examinations, and MetS was diagnosed using 2007 International Diabetes Federation criteria. The presence of adiponectin and its genotypes of single nucleotide polymorphisms (SNPs) rs266729 (-11377C/G), rs2241766 (+45T/G) and rs1501299 (+276G/T) was detected. RESULTS: (1) Serum adiponectin levels were negatively correlated with numerous CVD risk factors (all P<0.05), and following adjustments for confounding factors, a lower adiponectin level was an independent risk factor for MetS (odds ratio=5.59; 95% confidence interval: 1.90, 16.41). Central obesity and low levels of high-density lipoprotein cholesterol were positively associated with MetS and reduced serum adiponectin levels. (2) The genotype and frequencies of SNP-11377 and SNP+276 in a MetS group and non-MetS group were not significantly different. Subjects with genotype SNP+45 GG were at higher risk for MetS compared with subjects with genotypes SNP+45 TT (P=0.033) or TT+TG (P=0.021). Subjects with genotype SNP+276 TT or TT+TG had higher levels of serum adiponectin compared with subjects with SNP+276 GG (P=0.012 and 0.014, respectively). CONCLUSIONS:Adiponectin may be used as a predictive biomarker of MetS, and shows a significant association with CVD risk factors in Chinese adolescents. Adiponectin gene polymorphisms are associated with serum adiponectin concentrations and the presence of MetS.
Authors: Pía Riestra; Alicia García-Anguita; Miguel A Lasunción; Beatriz Cano; Manuel de Oya; Carmen Garcés Journal: Atherosclerosis Date: 2011-02-24 Impact factor: 5.162
Authors: Niina Siitonen; Leena Pulkkinen; Jaana Lindström; Marjukka Kolehmainen; Johan G Eriksson; Mika Venojärvi; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jaakko Tuomilehto; Matti Uusitupa Journal: BMC Med Genet Date: 2011-01-10 Impact factor: 2.103
Authors: Miguel Klünder-Klünder; Samuel Flores-Huerta; Rebeca García-Macedo; Jesús Peralta-Romero; Miguel Cruz Journal: BMC Public Health Date: 2013-01-30 Impact factor: 3.295